Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I did the search and it looks like you're wrong on your assessment.
Huh?? Please explain...
Yes, I can't wait to see how this plays out over the next couple of weeks and months. I, like so many others, believe this has bottomed out and we'll now see this gradually head north from these lows, and just in time for the proxy vote. Enjoy the ride...
The market hasn't opened yet, but hang on...
Yeah, now's probably not a good time to be shorting it. Many shorts will need to cover their margin calls. Going to be a tough day for the shorts and 13D gang, yet I repeat myself.
So today's incredibly positive mTNBC PR is hot air via paid announcement? And NP and SK need to go ASAP because of these types of announcements?
Why would you request LL for your father if you don't believe it works?
You hit the nail on the head, ER. They've soured so many on this board that every post now works against the 13D gang, and it becomes more and more desperate sounding as we get closer to the annual meeting. And now it's all about bouncing a $100 check 40 years ago and native American art.
Speaking of trustworthy, this is from the bottom of the article:
"Disclosure: Insider Financial and its owners do not have a position in the stocks posted and have posted this article for free without editorial input. "
Wrong - here are the "facts":
On January 10, 2019, Anthony D. Caracciolo resigned as a member of the Company’s board of directors. Mr. Caracciolo informed the Company of his intention to resign at the conclusion of a board meeting on January 4, 2019, and the resignation became effective on January 10, 2019.
https://www.sec.gov/Archives/edgar/data/1175680/000119312519006180/0001193125-19-006180.txt
When was he ever convicted of a felony??? Link please!
From gestalt2 on another board...
2012 cytodyn buys pro140, Nader is ceo at that time.
2013 Tony c is named chairman of board
2017 Tony named executive chairman, effectivly replacing Nader. Nader is still ceo but Tony is in charge of planning, business dev. And operations.
2018 cytodyn agrees to buy prostegene, Pestell is on bod now
In nov 2018, the tnbc trial is set to start, 1sr patient enrolled in august, after Pestell is fired in July. In august Pestell sues cytodyn. In July 2018 cytodyn has meeting with fda over prostagene. I think it is interesting that cytodyn found out what the status of prostagene’s diagnostic was in June, fired Pestell in July and got the cancer trial started in august. It seems obvious that Pestell was not starting the cancer trial until the prostagene deal went through.
It was April of 2018 that Tony was replaced by Scott Kelly as cob, Tony sues cytodyn as a result.
April 2020 the original BLA for combo was filed
May of 2020 is when the fda had some problem with it
July 2020is when we got the RTF.
Incell dx was brought on in July of 2019, Bruce Patterson was still on the board of directors on July of 2020.
I don’t know how this 13d group internally looked past this sequence of events relating to their own members and thinks they have any chance of replacing the Nader mgmnt team and bod. Tony, Pestell and Bruce are all in it for the money. The first think the 13d group wants to do is buy incell, at our expense to enriches Bruce and his investors. Just like what Tony did for Pestell. Nader has tried to navigate these expensive distractions by focusing on getting leronlimab through trials, raising money to pay for it and getting distribution deals. This is as plain as I can make it, don’t listen to this groups attempt to make everything a Nader problem, it is their doing from all the way back in 2017 when Tony, an ex gilead BP got involved.
And he (Caracciolo) was responsible for the acquisition of Prostagene. And now he's part of the 13D that many are now pumping. Yikes!
This is the "real deal"! And Caracciolo was responsible for the acquisition of Prostagene.
LOL
A New Drug Shows Promise for Helping COVID Long-Haulers Recover
"Erlanson enrolled in a double-blind clinical trial of a drug called leronlimab, an experimental CCR5 inhibitor designed specifically for long COVID. Erlanson did not know whether she received the drug or a placebo until the study was unblinded, at which time she received confirmation that she did receive the drug. But she says that noticed a marked improvement in her condition about three days after she received her first dose on March 16."
https://www.verywellhealth.com/long-covid-existing-treatment-patient-story-5189914
If you believe it's now a 2B, then explain why they submitted the first part of the BLA this week.
Easy - it didn't change. Please read the PR carefully.
The PR clearly says "Leronlimab has been studied in 16 clinical trials involving more than 1,200 people and met its primary endpoints in a pivotal Phase 3 trial (leronlimab combined with HIV standard care in patients with multi-drug resistance to current available classes of HIV drugs."
Actually...NOT great find. lol
The PR clearly says "Leronlimab has been studied in 16 clinical trials involving more than 1,200 people and met its primary endpoints in a pivotal Phase 3 trial (leronlimab combined with HIV standard care in patients with multi-drug resistance to current available classes of HIV drugs."
Look again. The PR clearly says "Leronlimab has been studied in 16 clinical trials involving more than 1,200 people and met its primary endpoints in a pivotal Phase 3 trial (leronlimab combined with HIV standard care in patients with multi-drug resistance to current available classes of HIV drugs."
You're confusing it with their NASH trial. So MANY great things going with this company and so many catalysts over the next few weeks that can send this sp through the ceiling!
Rolling reviews are for submitting the BLA in sections, and the FDA then reviews the partial submittals on a "rolling" basis. What CYDY has done is given us the dates for when they will be submitting each of the sections for the BLA. BTW, in case you haven't heard, their first piece (i.e. the Dose Justification Report) was submitted ON SCHEDULE. Isn't that GREAT NEWS?
CytoDyn Submits Dose Justification Report ON SCHEDULE to FDA for its BLA for HIV, and confirms 60th NASH patient enrolled AS PROMISED.
Yes, they OBVIOUSLY have ROLLING SUBMISSION APPROVAL. Glad you saw it.
Why what?
You must have missed the 8k PR that followed the cc and included a link to the webpage with the presentation.
A pop in the SP isn't proof of anything other than people are willing to pay more for the CYDY shares, and that can be driven by FUD or many other things.
I'm basing it off of their last PR that clearly says "Completion to allow for ROLLING SUBMISSION".
Okay, so you're suggesting they must not have applied for it because you didn't see it in a PR, yet they just released a PR that clearly says "Completion to allow for ROLLING SUBMISSION".
Perhaps you missed this...
CytoDyn’s Long-Hauler Trial a Resounding Success: Clear Pathway to Approval This Year
https://emerginggrowth.com/cytodyns-cydy-long-hauler-trial-a-resounding-success-clear-pathway-to-approval-this-year/
Just because the date had expired doesn't mean the FDA can't renew it. You're assuming the FDA refused to renew it?? Of course they renewed it or they wouldn't have given CYDY an RR in the first place. CytoDyn said they're submitting the BLA on a rolling basis in their last PR.
Easy - they wouldn't post rolling review dates on their PR if they hadn't received approval from the FDA to submit them on a rolling basis.
Okay, you're suggesting this BLA rolling timeline is a scam because they botched the submission. Got it!
So you're suggesting this BLA rolling timeline is a scam?
Are you suggesting they're making up their submittal dates and they cannot be submitting the BLA on a rolling basis?
Why would the FDA approve the Rolling Review and then refuse to renew it after it expired prior to resubmittal? There's no requirement for them to PR it again, nor would I expect it. And they clearly said they're submitting it on a Rolling Basis, with dates, so that's good enough for me.
Well, the good news is that it appears the FDA has agreed to continue accepting it on a rolling basis given that is how CytoDyn plans to submit it.
Are you suggesting they're not allowed to submit the BLA on a rolling basis between now and Oct, and the FDA will not allow or accept it?
You must not have read it, BUT it clearly says "Completion to allow for ROLLING SUBMISSION".
Not sure when you sold, but I still have MASSIVE gains from a 4-5 bagger - not losses. My only regret is that I'm not holding a larger bag, or should I say "sack"!